Business, energy, technology, markets and global industry news from Business News Today
PharmaDeviceNews
Editorial infographic highlighting bioAffinity Technologies’ $4 million financing and growing CyPath Lung sales, featuring lung diagnostic imagery, laboratory equipment and financial graphics illustrating shareholder dilution, cash runway and commercial expansion.
Medical Devices & Diagnostics

What bioAffinity Technologies’ $4m financing means for CyPath Lung growth

bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.

Read More
Editorial infographic illustrating Corcym’s Perceval Plus aortic heart valve, featuring an anatomical heart, prosthetic valve and clinical imaging, with MANTRA study highlights showing 99.7% freedom from valve deterioration in extended follow-up and remaining durability questions.
Medical Devices & Diagnostics

A sutureless heart valve showed 99.7% freedom from deterioration. What do Corcym’s seven-year data really establish?

Corcym's Perceval Plus reports 99.7% freedom from valve deterioration in extended follow-up. Examine the MANTRA data and durability questions.

Read More
Editorial infographic illustrating Affinia Therapeutics’ AFTX-201 BAG3 heart gene therapy programme, featuring an anatomical heart, DNA strands and clinical research imagery, with highlights on the 22-patient trial, promising animal results and unproven human safety and efficacy.
Pharma & Biotech

Affinia presents AFTX-201 preclinical data and UPBEAT trial design at HFSA 2026

Affinia advances AFTX-201 into a 22-patient BAG3 heart gene therapy trial after promising animal results. Human safety and efficacy remain unproven.

Read More
Editorial infographic highlighting Medincell’s second FDA-approved drug, Weltruza, featuring an injectable medicine, FDA approval symbol, U.S. launch map and graphics illustrating clinical evidence, royalty potential and commercial outlook.
Pharma & Biotech

Can Weltruza become Medincell’s next growth driver after Uzedy commercial success?

Medincell gains a second FDA-approved drug as Teva prepares Weltruza's U.S. launch. See the clinical evidence, royalties and commercial outlook.

Read More
Editorial infographic illustrating Carrot’s acquisition of GreenMan, featuring a virtual reality headset, cataract lens simulation software and intraocular lens models, with highlights on the supporting 609-patient study and expansion of VR eye-care technology beyond diagnostics.
Medical Devices & Diagnostics

Why Carrot is buying GreenMan InSightVR after a 609-patient cataract study revealed a striking difference

Carrot's GreenMan acquisition adds cataract lens simulation, backed by a 609-patient study, as VR eye-care technology expands beyond diagnostics.

Read More
Editorial infographic showing Oncomatryx’s OMTX305 in a tumor microenvironment, with immune T cells attacking cancer tissue and tumor-supporting fibroblasts, highlighting preclinical anti-tumor activity and unresolved clinical translation questions.
Pharma & Biotech

Can Oncomatryx OMTX305 overcome immune resistance in solid tumors?

Oncomatryx OMTX305 activates T cells and destroys tumor-supporting fibroblasts in preclinical cancer models. Examine the findings and limitations.

Read More
Editorial infographic illustrating GSK’s expanded AI drug discovery collaboration with Chai Discovery, featuring molecular protein-binding visuals, wet-lab testing, and key highlights on early binding success and unproven clinical and commercial outcomes.
Pharma & Biotech

Why GSK’s wet-lab validation gives Chai Discovery a stronger pharmaceutical industry foothold

GSK expands Chai Discovery AI collaboration after wet-lab success. See what the binding results establish and what remains unproven.

Read More
Editorial infographic showing Urolution Medical’s OpenFlo catheter with medical tubing and sterile equipment, highlighting FDA clearance for 30-day drainage, upcoming clinical studies and manufacturing considerations.
Medical Devices & Diagnostics

FDA clears Urolution’s redesigned urinary catheter, but can OpenFlo improve patient outcomes?

Urolution Medical's OpenFlo catheter gains FDA clearance for 30-day drainage. Clinical studies and manufacturing will determine its next steps.

Read More
Viz.ai’s HCM data push shows why cardiac AI is shifting from detection to care coordination
Pharma & Biotech

Secretome Therapeutics advances regenerative heart failure research with STM-01 trial data

Secretome Therapeutics reports early STM-01 safety data in 10 HFpEF patients, but unproven efficacy leaves bigger questions for future trials.

Read More
Representative image: Ophthalmology slit-lamp examination reflecting the unmet treatment need in neuropathic corneal pain as OKYO Pharma advances urcosimod toward the Phase 3 NEPTUNE trial.
Medical Devices & Diagnostics

Can Stuart Therapeutics’ ST-100 heal damaged corneas? A new FDA filing opens a critical test

Stuart Therapeutics files an FDA amendment for ST-100 corneal wound trials, with collagen repair evidence and 2027 milestones in focus.

Read More